CDC recommends Pfizer, Moderna instead of J&J for adults due to rare cases of blood clots

Advisory Committee on Centers for Disease Control and Prevention on Thursday recommended by Pfizer in Modernthe vaccine is over Johnson & Johnson‘s shot for adults aged 18 and over, after finding that dozens of people developed a rare blood clot after being vaccinated, all were hospitalized and nine died.

The Advisory Committee on Immunization Practices unanimously voted to recommend Pfizer and Moderna instead of Johnson & Johnson. CDC Director Rochelle Walensky still needs to consider the commission’s recommendation.

The CDC confirmed 54 cases of people who developed blood clots and showed low platelet counts, a new condition called thrombosis with thrombocytopenia syndrome, which mostly affects younger women. All patients were hospitalized, nine people died, and 36 were treated in intensive care.

“The rate of reporting TTS cases after Janssen vaccines is higher than previous estimates for men and women in a wider age range,” he told the advisory committee. Keipp Talbot, President of the CDC Subgroup on Vaccine and Safety.

Seven of the patients who died were women and two were men with a mean age of 45 years. Most of the deaths had underlying health problems such as obesity, hypertension, and diabetes. According to the CDC, the death reporting rate was 0.57 deaths per million doses given.

“When we reviewed these cases, we were amazed at how quickly the patient’s condition deteriorated and led to death,” he told the advisory committee. Isaac See of the CDC Vaccine Safety Team.

According to the CDC, patients usually developed symptoms 9 days after vaccination and were hospitalized 5 days after the onset of symptoms. The vast majority of patients were women, a total of 37, and the mean age was 44 years. TTS was developed by seventeen men.

Penny Heaton of Johnson & Johnson, head of global vaccine therapy, defended the company’s shot during the meeting, saying it “saves lives here in the United States and on all continents around the world.”

“It’s easy to store and transport,” Heaton said. “In many low- and middle-income countries, our vaccine is the most important and sometimes the only option in the United States, given that its permanent protection may be a priority for people who cannot or do not want to return after multiple vaccinations.”

Heaton said J&J recognizes vaccine-related TTS incidents and that the condition can be fatal, although cases are rare. She said J & J’s safety and well-being remain a major priority for the company, and the company is conducting several studies to identify risk factors associated with the development of TTS.

April is the Food and Drug Administration and the CDC stopped briefly use of Johnson & Johnson disposable vaccine after six adult women developed blood clots and low platelet counts at the same time.

A week later the FDA and CDC raised a pause on J&J recordings after an independent advisory commission stated that the benefits of the recordings outweighed the risks. The commission at the time did not recommend restricting recordings based on age or gender. He suggested that the FDA add a warning label for women under the age of 50.

The FDA has told healthcare professionals not to give the J&J booster to people who have a history of developing TTS after the first vaccination. The FDA also said that J&J vaccines should not be given to people who have received AstraZeneca, even though AstraZeneca is not approved for use in the United States.

CDC experts said Thursday that no cases of TTS have been detected in people who received J&J booster doses, although the number of booster drugs is relatively small.

“Currently available evidence supports a causal link between TTS and Janssen COVID-19,” the FDA wrote in an information sheet for healthcare providers.

October FDA and CDC authorized J&J amplifiers for all adults at least two months after receiving the first J&J vaccination. According to the CDC, more than 800,000 people received J&J amplifiers. People who received primary vaccination with J&J injection it can also be boosted with Pfizer or Moderna.

That’s breaking news. Check again for updates.